The press release below appears on PR Newswire.
PITTSBURGH, Dec. 8, 2016 /PRNewswire/ — PANTHERx Specialty Pharmacy was recently ranked #1 in the Zitter Health Insights Patient Satisfaction Survey for Q3 2016. PANTHERx received one of the highest scores ever attained since the study, which assesses all specialty pharmacies in the U.S., was created in 2014.
The Zitter Health Insights survey assesses numerous aspects of patient satisfaction and analyzes responses from more than 10,000 specialty pharmacy patients across all specialty pharmacies every year. By leveraging an external party to aggregate unbiased patient feedback, specialty pharmacies are able to objectively assess how they are perceived by their patients as well as benchmark how they compare to competitor performance in the areas of patient perception, access, and adherence.
The overall key measure of the survey is the Net Promoter Score (NPS) – an index of -100 to 100 that measures patients’ willingness to recommend their pharmacy to others. PANTHERx Specialty Pharmacy’s NPS across all categories was 98. This score is the highest across all pharmacies assessed and 47 points higher than the average of all 38 U.S. specialty pharmacies evaluated in the survey.
“We are honored and feel that these results further validate our mission to redefine the care that is provided in Specialty Pharmacy.” says PANTHERx Specialty Pharmacy CEO, Dr. Gordon Vanscoy. “Having our patient’s voice heard and knowing they value our high-touch approach is credit to the great team of colleagues at PANTHERx who go out of their way each and every day to make sure our patient’s unique needs are met.”
A 98 is one of the highest scores ever achieved by any specialty pharmacy surveyed by Zitter Health Insights over the past 2 years that it has been conducting the survey, and 24 points higher than second place, Amber Pharmacy, which scored a 74 within the same survey period between August 1st and October 24th 2016.
“We firmly believe that patient satisfaction plays a pivotal role in medication adherence and enhances our ability to educate patients on their therapy.” says Dr. Douglas Gebhard, VP of Quality & Education at PANTHERx. “Having direct and unfiltered insights from our patients enables us to systematically improve the quality of care and promote positive patient outcomes.”
In addition, Zitter Health Insights is able to break out results for individual therapeutic categories which showed PANTHERx Specialty Pharmacy among the top in many categories and led in the HIV therapeutic category with an NPS of 100.
The NPS is determined by asking patients on a scale of 0 to 10 how likely they would be to recommend a friend/family member to PANTHERx Specialty Pharmacy. Patients responding with a 9 or 10 improve the score, while patient’s responding with 0 to 6, detract from the overall score. Approximately 81 percent of patients rated PANTHERx a “10,” and 18 percent of patients gave PANTHERx a rating of “9,” resulting in a total of 98 percent of patients giving PANTHERx Specialty Pharmacy the highest rating possible.